Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group

Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting

(2015) Olivier Bylicki et al.   Journal of Thoracic Oncology

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study

(2015) Akira Kawai et al.   LANCET ONCOLOGY

Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group

(2013) S. Cousin et al.   ANNALS OF ONCOLOGY

Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-a-vis Temozolomide and Antiangiogenics

(2013) S. Stacchiotti et al.   CLINICAL CANCER RESEARCH

Response to chemotherapy of solitary fibrous tumour: A retrospective study

(2013) S. Stacchiotti et al.   EUROPEAN JOURNAL OF CANCER

Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)

(2013) T. Valentin et al.   INVESTIGATIONAL NEW DRUGS

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

(2013) Juliann Chmielecki et al.   NATURE GENETICS

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

(2013) Dan R Robinson et al.   NATURE GENETICS

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy

(2012) N. Penel et al.   ANNALS OF ONCOLOGY

Sunitinib malate in solitary fibrous tumor (SFT)

(2012) S. Stacchiotti et al.   ANNALS OF ONCOLOGY

A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas

(2012) Axel Le Cesne et al.   EUROPEAN JOURNAL OF CANCER

Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

(2012) C.A. Stiller et al.   EUROPEAN JOURNAL OF CANCER

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

(2012) Winette TA van der Graaf et al.   LANCET

Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor

(2011) Min S. Park et al.   CANCER

Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma

(2010) Javier Martinez-Trufero et al.   ANTI-CANCER DRUGS

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

(2010) Daniel D. Von Hoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Brief Report: Activity of Imatinib in a Patient with Platelet-Derived-Growth-Factor Receptor Positive Malignant Solitary Fibrous Tumor of the Pleura

(2010) Tommaso De Pas et al.   Journal of Thoracic Oncology

Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

(2009) George D. Demetri et al.   JOURNAL OF CLINICAL ONCOLOGY

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

(2009) C. Forni et al.   MOLECULAR CANCER THERAPEUTICS

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Phase II Trial of Weekly Paclitaxel for Unresectable Angiosarcoma: The ANGIOTAX Study

(2008) Nicolas Penel et al.   JOURNAL OF CLINICAL ONCOLOGY